Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Clinical Question and Scope For a person with Type 2 diabetes who is starting a glucagon-like peptide-1 receptor agonist (GLP-1RA) or tirzepatide, which retinal findings should influence interpretation of the evidence and coordination of care? This review addresses that clinical question. Tirzepatide activates both glucose-dependent insulinotropic polypeptide and GLP-1 receptors; it is considered separately where its evidence differs.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.